A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. The drug, called gepotidacin ...

Get Instant Summarized Text (Gist) The US has approved a new antibiotic, Blujepa, for treating uncomplicated urinary tract infections in women and girls aged 12 and older. This marks the ...

A new treatment for gonorrhea shows promise, which is welcome news with global rates of the sexually transmitted infection on the rise and antibiotic resistance becoming more prevalent.

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics.” So the team grew the bacteria found in ...

Researchers believe they have identified a new class of antibiotics, nearly three decades since the last new one came to market. Teams at McMaster University in Ontario, Canada and the University ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The global proliferation of antibiotic resistance genes (ARGs) poses a significant threat to the efficacy of antibiotic-based treatments for diseases. Effective monitoring of ARGs across both ...

The molecular targets of existing antibacterial agents are limited. Given the rise of antibiotic resistance, it is vital to identify novel bacterial processes that can be therapeutically targeted.

UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.